These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9865327)

  • 1. Prevention of islet graft destruction in diabetic mice and rats by temporary anti-IL-2 receptor therapy: comparison of different strategies.
    Kuttler B; Mathieu C; Bulfone-Paus S; Bouillon R; Diamantstein T; Hahn HJ
    Transplant Proc; 1998 Dec; 30(8):4140-2. PubMed ID: 9865327
    [No Abstract]   [Full Text] [Related]  

  • 2. Interleukin 2 receptor-targeted therapy in islet transplantation research.
    Hahn HJ; Kuttler B; Volk HD; Lucke S; Diamantstein T
    Horm Metab Res Suppl; 1990; 25():177-80. PubMed ID: 2088963
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevention of autoimmune but not allogeneic destruction of grafted islets by different therapeutic strategies.
    Kuttler B; Rösing K; Lehmann M; Brock J; Hahn HJ
    J Mol Med (Berl); 1999 Jan; 77(1):226-9. PubMed ID: 9930969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nondepleting anti-CD4 and soluble interleukin-1 receptor prevent autoimmune destruction of syngeneic islet grafts in diabetic NOD mice.
    Drage M; Zaccone P; Phillips JM; Nicoletti F; Dawson J; Andrew Bradley J; Cooke A
    Transplantation; 2002 Sep; 74(5):611-9. PubMed ID: 12352875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of temporary IL-2 receptor MAB therapy on islet allograft in autoimmune diabetes.
    Hahn HJ; Kuttler B; Lucke S; Dunger A; Besch W; Volk HD; Diamankstein T
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2711-3. PubMed ID: 2495678
    [No Abstract]   [Full Text] [Related]  

  • 6. Anti-TCR mAb induces peripheral tolerance to alloantigens and delays islet allograft rejection in autoimmune diabetic NOD mice.
    Deng R; Khattar M; Xie A; Schroder PM; He X; Chen W; Stepkowski SM
    Transplantation; 2014 Jun; 97(12):1216-24. PubMed ID: 24854475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporary anti-CD-25 treatment results in tolerance development in syngeneically grafted autoimmune diabetic recipients.
    Hahn HJ; Kuttler B; Dunger A; Lucke S; Volk HD; Diamantstein T
    Transplant Proc; 1991 Feb; 23(1 Pt 1):741-2. PubMed ID: 1990673
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of anti-interleukin-2 receptor antibody treatment on recurrent autoimmune insulitis in the BB rat.
    Woehrle M; Pullmann J; Stuenkel KG; Bretzel RG; Federlin K
    Transplant Proc; 1994 Apr; 26(2):734-5. PubMed ID: 8171631
    [No Abstract]   [Full Text] [Related]  

  • 9. Early graft failure of xenogeneic islets in NOD mice is accompanied by high levels of interleukin-1 and low levels of transforming growth factor-beta mRNA in the grafts.
    Gysemans CA; Waer M; Valckx D; Laureys JM; Mihkalsky D; Bouillon R; Mathieu C
    Diabetes; 2000 Dec; 49(12):1992-7. PubMed ID: 11117999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy with nondepleting anti-CD4 monoclonal antibodies but not CD28 antagonists protects islet graft in spontaneously diabetic nod mice from autoimmune destruction and allogeneic and xenogeneic graft rejection.
    Guo Z; Wu T; Kirchhof N; Mital D; Williams JW; Azuma M; Sutherland DE; Hering BJ
    Transplantation; 2001 Jun; 71(11):1656-65. PubMed ID: 11435979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of autoimmune islet allograft destruction by engraftment of donor T cells.
    Bartlett ST; Schweitzer EJ; Kuo PC; Johnson LB; Delatorre A; Hadley GA
    Transplantation; 1997 Jan; 63(2):299-303. PubMed ID: 9020334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-4 or interleukin-10 expressed from adenovirus-transduced syngeneic islet grafts fails to prevent beta cell destruction in diabetic NOD mice.
    Smith DK; Korbutt GS; Suarez-Pinzon WL; Kao D; Rajotte RV; Elliott JF
    Transplantation; 1997 Oct; 64(7):1040-9. PubMed ID: 9381527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin 2 receptor targeted immunotherapy in the prevention of autoimmune beta-cell destruction as observed in diabetic BB/OK rats grafted with BB/OK rat islets.
    Hahn HJ; Kauert C; Dunger A; Kuttler B; Diamantstein T
    Autoimmunity; 1989; 5(1-2):139-42. PubMed ID: 2519014
    [No Abstract]   [Full Text] [Related]  

  • 14. Beta cell destruction of pancreatic islets transplanted into diabetic BB/OK rats may be reflected by increased antibody-mediated anti-islet cytotoxicity.
    Schröder D; Wanka H; Hehmke B; Klöting I; Köhler E; Knospe S; Schmidt S
    Diabetes Res; 1990 Sep; 15(1):27-32. PubMed ID: 2132197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-CD4/CyA therapy causes prevention of autoimmune but not allogeneic destruction of grafted islets in BB rats.
    Kuttler B; Rösing K; Hahn HJ
    Transplant Proc; 1997 Jun; 29(4):2163-5. PubMed ID: 9193572
    [No Abstract]   [Full Text] [Related]  

  • 16. [The effects of NKG2D mAb on the survival of allogeneic transplanted islets in spontaneous diabetic nonobese diabetic mice].
    Pan H; Lu YR; Zhang ZD; Jin X; Wei LL; Yuan Y; Lu HM; Mai G
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Sep; 41(5):836-9, 848. PubMed ID: 21302453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Encapsulated islet iso-, allo-, and xenografts in diabetic NOD mice.
    Weber CJ; Hagler M; Konieczny B; Chryssochoos J; Rajotte R; Lakkis F; Lowry R
    Transplant Proc; 1995 Dec; 27(6):3308-11. PubMed ID: 8539965
    [No Abstract]   [Full Text] [Related]  

  • 18. The capsular overgrowth on microencapsulated pancreatic islet grafts in streptozotocin and autoimmune diabetic rats.
    Fritschy WM; de Vos P; Groen H; Klatter FA; Pasma A; Wolters GH; van Schilfgaarde R
    Transpl Int; 1994 Jul; 7(4):264-71. PubMed ID: 7916926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Islet graft primary nonfunction and its prevention.
    Arita S; Smith CV; Nagai T; Sakamoto Y; Maruyama M; Mullen Y
    Transplant Proc; 2000 Nov; 32(7):1667. PubMed ID: 11119883
    [No Abstract]   [Full Text] [Related]  

  • 20. The syngeneic islet transplantation to study physiology and pathophysiology of pancreatic beta-cells.
    Hahn HJ; Kuttler B
    Adv Exp Med Biol; 1997; 426():411-9. PubMed ID: 9544301
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.